台股 » 個股 » 醣聯 » 籌碼相關 » 券商分點績效

醣聯

(4168)
可現股當沖
  • 股價
    25.40
  • 漲跌
    ▼0.10
  • 漲幅
    -0.39%
  • 成交量
    180
  • 產業
    上櫃 生技醫療類股
  • 102人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
醣聯 (4168)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/17 ~ 2024/05/01     後一日»

券商獲利排行 - 2024/04/17 ~ 2024/05/01

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.68%22.48.613.7-498012925.625.625.725.4
  1.19%11.1011.1-3603625.7025.725.4
  1.95%10.1010.1-2002025.9025.925.4
  1.67%9.5-0.29.7-2112225.926.125.925.4
  1.66%8.608.6-2002025.8025.825.4
  1.70%8.408.4-1901925.8025.825.4
  1.89%8.308.3-1701725.9025.925.4
  1.20%6.806.8-2202225.7025.725.4
  1.76%6.84.62.2-4111525.825.525.925.4
  0.77%6.11.15-15163125.725.725.725.4
  2.31%606-100102602625.4
  1.65%5.55.10.5-1121325.625.425.925.4
  1.61%5.405.4-1301325.8025.825.4
  2.01%5.205.2-1001025.9025.925.4
  0.97%505-2002025.7025.725.4
  2.78%55007725.725.32625.4
  1.98%4.60.64-81925.825.325.925.4
  1.67%4.34.300101025.825.52625.4
  1.59%4.10.53.6-911025.825.325.825.4
  1.33%4.13.70.4-1111225.725.525.825.4
  1.91%3.93.80.118725.625.325.825.4
  0.94%3.90.33.6-1511625.625.425.625.4
  1.14%3.803.8-1301325.7025.725.4
  3.42%3.603.6-40426.3026.325.4
  2.50%3.303.3-50526.1026.125.4
  1.56%3.20.42.8-61825.825.425.825.4
  1.34%3.10.62.5-62925.725.425.825.4
  2.31%303-5052602625.4
  0.35%2.702.7-3003025.5025.525.4
  1.03%2.702.7-1001025.7025.725.4
  0.94%2.402.4-1001025.6025.625.4
  1.17%2.40.91.5-53825.625.425.725.4
  0.88%2.302.3-1001025.6025.625.4
  1.74%2.302.3-50525.9025.925.4
  2.74%2.202.2-30326.1026.125.4
  0.12%2.15.4-3.39655525.825.725.825.4
  1.00%21.30.8-25825.625.425.725.4
  2.59%202-30326.1026.125.4
  0.78%202-1001025.6025.625.4
  1.93%202-40425.9025.925.4
  1.93%202-40425.9025.925.4
  0.78%21.60.4-191025.725.725.825.4
  1.86%1.91.80.114325.625.325.925.4
  1.24%1.91.80.126425.525.425.825.4
  0.90%1.901.9-80825.6025.625.4
  2.31%1.801.8-3032602625.4
  0.97%1.801.8-70725.7025.725.4
  1.71%1.71.70.114325.625.325.925.4
  1.13%1.72-0.326425.725.52625.4
  0.56%1.71.60.12121025.425.325.525.4

券商虧損排行 - 2024/04/17 ~ 2024/05/01

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -3.14%-27.5-27.2-0.3-3313425.726.225.325.4
  -2.27%-18.9-0.3-18.631321262625.725.4
  -1.96%-15.30-15.32930025.925.925.825.4
  -1.69%-140-143232025.825.8025.4
  -0.58%-12.7-0.3-12.475861125.625.625.525.4
  -1.49%-11.50-11.53030025.825.8025.4
  -0.40%-9.3-11.21.9-9809025.725.725.625.4
  -1.60%-80-8-200202502525.4
  -1.96%-6.60-6.61313025.925.92625.4
  -2.31%-60-6101002626025.4
  -1.56%-5.70.2-5.81214225.925.92625.4
  -0.79%-5.5-1.6-3.912271425.725.725.625.4
  -1.62%-5.4-5.400131325.926.125.725.4
  -1.77%-5.4-2.2-3.2812425.725.825.325.4
  -0.55%-5.40-5.43438425.625.625.625.4
  -0.95%-4.90.4-5.31820225.725.725.925.4
  -0.21%-43.1-7.138733525.625.625.725.4
  -2.20%-40-47702626025.4
  -1.71%-4-1.7-2.359425.725.925.425.4
  -0.47%-3.7-1.1-2.610312125.625.725.625.4
  -2.31%-3.60-3.66602626025.4
  -1.04%-3.5-2.8-0.71131125.625.725.525.4
  -0.42%-3.3-0.6-2.72831325.525.525.325.4
  -0.79%-3.2-1-2.3916625.625.625.525.4
  -0.99%-30-3-1201225.2025.225.4
  -1.27%-30-399025.725.7025.4
  -1.09%-2.80-2.81010025.725.7025.4
  -1.36%-2.80-2.888025.825.8025.4
  -1.05%-2.70-2.7810225.725.725.825.4
  -2.88%-2.2-2.2003325.726.125.325.4
  -1.68%-2.2-0.7-1.525225.825.925.625.4
  -0.57%-2.10-2.11414025.525.5025.4
  -1.11%-2-0.1-1.957125.725.725.625.4
  -1.48%-1.9-1.1-0.825325.725.825.425.4
  -0.28%-1.9-53.1-15112625.726.125.625.4
  -0.37%-1.80.1-1.91419525.525.525.625.4
  -0.99%-1.80-1.877025.725.7025.4
  -0.25%-1.81.2-2.915271225.625.625.725.4
  -1.69%-1.80-1.834025.825.825.625.4
  -0.95%-1.70-1.777025.625.6025.4
  -3.00%-1.60-1.622026.226.2025.4
  -0.76%-1.6-1-0.628625.625.725.525.4
  -1.97%-1.5-0.6-0.923125.725.925.325.4
  -0.59%-1.50-1.51010025.625.6025.4
  -0.84%-1.50-1.567025.625.625.425.4
  -1.17%-1.50-1.545025.725.725.525.4
  -2.87%-1.50-1.522026.226.2025.4
  -2.90%-1.5-0.8-0.712125.826.125.325.4
  -0.96%-1.5-1.5006626.126.225.925.4
  -0.33%-1.5-2.91.4-1171825.625.925.525.4
醣聯攜日商開發骨質疏鬆相似藥 一期臨床納入首位受試者Anue鉅亨-2023/05/23
醣聯 相關文章
醣聯 相關影音